Why patients switch from Compounded tirzepatide to Mounjaro
- FDA-approved finished product — full regulatory oversight on brand
- Insurance now covering Mounjaro
- FDA compounding restrictions changing supply availability
Dose conversion: Compounded tirzepatide → Mounjaro
Use this table as a starting reference only. Final dose depends on your tolerance, weight-loss trajectory, and prescriber guidance. Never self-titrate based on a chart.
| Compounded tirzepatide dose | Mounjaro dose | Note |
|---|---|---|
| 0.25 mg/week | 0.25 mg/week | Starting dose — identical |
| 0.5 mg/week | 0.5 mg/week | — |
| 1 mg/week | 1 mg/week | — |
| 1.7 mg/week | 1.7 mg/week (Wegovy only) | — |
| 2 mg/week | 2.4 mg/week (Wegovy max) | — |
Transition timeline
Plan on 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark on the new medication.
Week −2: Decision + prescriber alignment
Confirm with your prescriber: dose-equivalent target, expected side-effect profile differences (tirzepatide → tirzepatide), insurance implications.
Week −1: Last Compounded tirzepatide dose
Continue your current Compounded tirzepatide schedule. Compounded tirzepatide has a long half-life — semaglutide ~1 week, tirzepatide ~5 days — so effects persist for days after stopping.
Week 0: First Mounjaro dose
Start Mounjaro at your equivalent dose (see table below). Combined effect may be elevated in the first week as Compounded tirzepatide clears.
Weeks 1-4: Stabilization
Side-effect profile shifts. GI symptoms (nausea, constipation) may be more pronounced. Track weight + appetite.
Weeks 4-12: Re-evaluation
Compare outcomes to your Compounded tirzepatide baseline. If weight-loss trajectory hasn't improved by week 12, discuss whether the switch was right.
Beyond 12 weeks
If outcomes good, continue. If switch underperformed Compounded tirzepatide, discuss reverting or trying a third option (often semaglutide-based).
FAQ — Compounded tirzepatide → Mounjaro
Can I take Compounded tirzepatide and Mounjaro together?
No. Both contain tirzepatide — taking them together is effectively double-dosing the same medication. Stop Compounded tirzepatide before starting Mounjaro.
Will I lose ground when switching from Compounded tirzepatide to Mounjaro?
Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Compounded tirzepatide efficacy. Plan and 12-week evaluation window.
Does insurance cover Mounjaro if it covered Compounded tirzepatide?
Mounjaro is FDA-approved — insurance coverage is more typical. Verify formulary status and whether prior authorization is required for Mounjaro specifically.
How long does Compounded tirzepatide stay in my system after the last dose?
Tirzepatide has a ~5-day half-life — effects taper over 3-4 weeks after the last injection.
Cost comparison
Cash-pay pricing differs significantly between Compounded tirzepatide and Mounjaro. Run the true-cost calculator with your insurance details for an apples-to-apples comparison including coupons and patient assistance programs. Open true cost calculator →
Provider match
Find a provider that offers Mounjaro
Continuity of care matters during a switch. We compared 12+ telehealth providers ranked by Mounjaro availability, price, and prescriber accessibility.
See top Mounjaro providers →Affiliate disclosure: we earn commission on provider sign-ups. Learn more
Next steps
Before switching, read our full Compounded tirzepatide review and Mounjaro review. For provider options that carry both medications, see our Compounded tirzepatide vs Mounjaro comparison and Compounded tirzepatide alternatives hub.
Not medical advice. Switching GLP-1 medications must be done with prescriber supervision. This guide is editorial summary based on published prescribing information and clinical guidance. Full medical disclaimer.